Clinical trial · Interventional
The Short-term Impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on Respiratory Function in Patients With Lung Cancer
NCT06172959CI-TRIAL-00080843completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to examine the short-term impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on respiratory function in patients with lung cancer. As a secondary outcome, this research will evaluate the effect of the music intervention on respiratory quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Therapeutic Singing (TS) | Behavioral | — | UNRESOLVED |
| Vocal Intonation Therapy (VIT) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Vocal Therapy Group
- description
- Participants in this group will receive Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) for up to three weeks
- interventionNames
- Behavioral: Vocal Intonation Therapy (VIT)
- Behavioral: Therapeutic Singing (TS)
Primary outcomes (6)
- measure
- Change in Maximum Phonation Time (MPT) in seconds
- timeFrame
- Baseline, up to 30-minutes (Post-Intervention)
- description
- Maximum Phonation Time (MPT) measures the number of seconds a participant can sustain a phonated sound.
- measure
- Respiratory Rate
- timeFrame
- Up to 30-minutes
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Participants will include three patients diagnosed with lung cancer, stages I-III, who have undergone a thoracentesis or thoracotomy in the last 12 months. Thoracic surgical procedures include pulmonary lobectomy or cancer-related surgical procedure (e.g., pneumonectomy). This diagnosis must be made by the patient's oncologist and medical team. * The age range will be 40 to 80 years old. Both female and male participants from any race and ethnicity will be included in the study. * The study will include English and Spanish speakers only. * Patients must have less than five years of voice training experience (e.g., choir, private voice lessons). Exclusion Criteria: * Patients in respiratory failure * Individuals with severe neurological and hearing impairments. * Patients with diagnosed dysphonia and individuals who have undergone a laryngectomy * Participants that do not have access to an electronic device, either an iPad, tablet, or laptop, as well as reliable internet access. They will also need to have adequate knowledge of technology or participate with a caregiver who knows how to navigate Zoom. * Participants who do not have access to a quiet space. Headphones are optional for this study. * Prisoners * Persons under the age of 40 or over the age of 80.
References
Publications (0)
Data not yet available
No reference posted for this study.